Capital III Lp Aisling serves as Executive at Durata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital III Lp Aisling has executed 5 insider transactions totaling $5.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 11, 2015 involved purchasing 200 shares valued at $5.5K.
Capital III Lp Aisling currently holds 3,796,362 shares of Durata Therapeutics, Inc. (DRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital III Lp Aisling has been a net buyer of DRTX stock. They have purchased $5.4M and sold $0 worth of shares.
Capital III Lp Aisling's most recent insider trade was on Dec 11, 2015, when they purchased 200 shares at $27.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 6, 2014 | LOXO | $5.4M | Purchase | 413,077 | $13.00 | Discretionary |
| May 20, 2014 | DRTX | $0 | Other | 3,528 | $N/A | Discretionary |
| May 20, 2014 | DRTX | $0 | Other | 745,730 | $N/A | Discretionary |